Namely, MUC16 scored 10/15 (not highlighted in the Target Score graph) and, more strikingly, CD44 (not highlighted in the Target Score graph), one of the most studied glycoproteins in bladder cancer, frequently suggested as a biomarker of cancer stem cells, scored 5/15 (Fig. 2D). This evidence concerns the gene CD44 and cancer.